Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Passive immunization in murine cryptococcosis.

× No keyword cloud information.

28 in total

1. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide.

Authors: J E Sanford; D M Lupan; A M Schlageter; T R Kozel
Journal: Infect Immun Date: 1990-06 Impact factor: 3.441

Review 2. Antibody immunity and invasive fungal infections.

Authors: A Casadevall
Journal: Infect Immun Date: 1995-11 Impact factor: 3.441

3. Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis.

Authors: M M Hobbs; J R Perfect; D L Granger; D T Durack
Journal: Infect Immun Date: 1990-07 Impact factor: 3.441

4. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.

Authors: Robert A Larsen; Peter G Pappas; John Perfect; Judith A Aberg; Arturo Casadevall; Gretchen A Cloud; Robert James; Scott Filler; William E Dismukes
Journal: Antimicrob Agents Chemother Date: 2005-03 Impact factor: 5.191

Review 5. Cryptococcal interactions with the host immune system.

Authors: Kerstin Voelz; Robin C May
Journal: Eukaryot Cell Date: 2010-04-09

6. Effects of cyclosporine in experimental cryptococcal meningitis.

Authors: J R Perfect; D T Durack
Journal: Infect Immun Date: 1985-10 Impact factor: 3.441

7. Immunogenic fractions of Cryptococcus neoformans.

Authors: J R Graybill; D C Straus; T J Nealon; M Hague; R E Paque
Journal: Mycopathologia Date: 1982-04-23 Impact factor: 2.574

8. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors: J Mukherjee; M D Scharff; A Casadevall
Journal: Infect Immun Date: 1995-09 Impact factor: 3.441

9. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Authors: A Casadevall; W Cleare; M Feldmesser; A Glatman-Freedman; D L Goldman; T R Kozel; N Lendvai; J Mukherjee; L A Pirofski; J Rivera; A L Rosas; M D Scharff; P Valadon; K Westin; Z Zhong
Journal: Antimicrob Agents Chemother Date: 1998-06 Impact factor: 5.191

10. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors: J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal: Antimicrob Agents Chemother Date: 1994-03 Impact factor: 5.191